Financhill
Back

Achilles Therapeutics PLC Quote, Financials, Valuation and Earnings

Achilles Therapeutics PLC Price Quote

$1.06

Achilles Therapeutics PLC Key Stats

Sell
43
Achilles Therapeutics PLC (ACHL) is a Sell

Day range:
$1.01 - $1.08
52-week range:
$0.63 - $1.76
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.42%

Volume:
410.9K
Avg. volume:
130.9K
1-year change:
32.83%
Market cap:
$43.6M
Revenue:
$0
EPS:
$-1.65

How Much Does Achilles Therapeutics PLC Make?

Data Unavailable

Is Achilles Therapeutics PLC Growing As A Company?

Data Unavailable

Achilles Therapeutics PLC Stock Price Performance

What Is Achilles Therapeutics PLC 52-Week High & Low?

Achilles Therapeutics PLC Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Achilles Therapeutics PLC?

Is Achilles Therapeutics PLC Cash Flow Positive?

Data Unavailable

Achilles Therapeutics PLC Return On Invested Capital

Data Unavailable

Achilles Therapeutics PLC Earnings Date & Stock Price

Achilles Therapeutics PLC Competitors

Achilles Therapeutics PLC Dividend Yield

Achilles Therapeutics PLC Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -17.07%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 4.00
Upside from Last Price: 277.36%

Major Shareholders

  • How many ACHL shares are owned by institutional investors?
    24.2M ACHL shares are owned by institutional investors
  • How many ACHL shares are owned by insiders?
    0 ACHL shares are owned by insiders